Clinical trial
The Pain Pen for Breakthrough Cancer Pain
NCT00125801 · Erasmus Medical Center, Other · Terminated
Key facts
| NCT number | NCT00125801 |
|---|---|
| Title | The Pain Pen for Breakthrough Cancer Pain |
| Official title | Breakthrough Cancer Pain: A Randomized Trial Comparing Oral Morphine Immediate Release and Self-Administration of Subcutaneous Hydromorphone Using an Injection Pen |
| Lead sponsor | Erasmus Medical Center, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neoplasms, Pain |
| Intervention type | Drug |
| Interventions | Subcutaneous hydromorphone delivered by pain pen |
| Enrollment | 50 |
| Start date | Aug 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Aug 2, 2005 |
| Last update posted | Oct 15, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: